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Summary 
Human leukocyte antigen DM (HLA-DM) molecules are 
structurally related to classical MHC class II molecules 
and reside in the lysosomallke compartment where 
class II-restricted antigen processing Is thought to oc- 
cur. Yutsnt cell lines tacking HLA-DM ere defective In 
antigen processing and accumulate cuss II molecules 
associated wlth a nested set of invariant chain-derived 
peptkfes (clsas II-sssoctated InvarIant chain pepWe& 
CLIP). Here we show thst HLA-DM cstalyxes the dlsso- 
elation of CLIP from MHC class II-CLIP complexes In 
vitro and facilitates the binding of antigenic peptides. 
The reactlon has an acidic pH optimum, consistent 
with its occurrence In a lysosome-like compartment 
in vivo. Antibody blocking experiments suggest that 
a transient interaction between HLA-DM and the MHC 
class II-CLIP complex is required. 
Introduction 
Major histocompatibiiitycompiex(MHC)class ii molecules 
are heterodimeric giycoproteins that present peptides de- 
rived from foreign antigens to CD4 T helper ceils. Foiiow- 
ing biosynthesis, the class ii a and 8 subunits assemble 
in the endopiasmic reticulum as a nonameric complex with 
trimers of the nonpolymorphic invariant (I) chain (reviewed 
by Cresswell, 1994a). The abl complex then moves to the 
trans-Goigi, where signals in the cytoplasmic tail of the I 
chain (Bakke and Dobberstein, 1990) divert the complex 
to endosomeliysosome-like vesicles called MHC class ii 
compartments (MIfC; Peters et al., 1991). The I chain also 
prevents the binding of peptides by the afl dimers (Roche 
and Cresswell, 1990; Newcomb and Cresswell, 1993a) 
until they reach the MIIC, where the I chain is degraded 
(Bium and Cresswell, 1988; Marie et al., 1994). Following 
I chain proteoiysis, the a8 dimers are loaded with peptides, 
derived from internalized pathogens or endogenous pro- 
teins present within the endocytic pathway, and trans- 
ported to the ceil surface. 
Class ii-restricted antigen processing in a group of mu- 
tant human ceil lines (e.g., T2.DR3, .174.DR3, and 9.5.3) 
is defective in that they cannot process and present intact 
protein antigens, but can present exogenousiy supplied 
peptides (Meliins et al., 1990; Riberdy and Cresswell, 
1992; Ceman et al., 1992). Although expressed on the ceil 
surface at wild-type levels, class ii molecules from the 
mutants are different from those from wild-type ceils in 
that they lack expression of certain antibody epitopes and 
dissociate in the detergent SDS (Meiiins et al., 1990; Rib- 
erdy et al., 1992). SDS stability of class II molecules is 
correlated with peptide binding (Germain and Hendrix, 
1991), suggesting that those isolated from the mutants 
lack associated peptides. In fact, human leukocyte antigen 
DR (HtA-DR) molecules in the mutant cell lines are com- 
plexed with a set of peptides derived from residues 61-104 
of the I chain, class ii-associated invariant chain peptides 
(CLIP) (Riberdy et al., 1992; Sette et al., 1992; Awa and 
Cresswell, 1994). The defect in these cell lines is caused 
by the lack of expression of the MHClinked genes HLA- 
DMA or HLA-DMB or both (Morris et al., 1994; Fling et al., 
1994; Denzin et al., 1994) which encode a class II-like 
molecule (Kelly et al., 1991). Unlike classical class II mole- 
cules, HLA-DM is not expressed on the cell surface, but 
is localized in the MIIC (Karlsson et al., 1994; Sanderson 
et al., 1994; Robbins et al., submitted). Neither HLA-DM 
nor the murine equivalent, H-2M, significantly associates 
with the I chain, and their subcellular localization is inde- 
pendent of I chain and class II expression (Denzin et al., 
1994; Karfsson et al., 1994). 
Class II CLIP complexes have been found in wild-type 
ceils, implying that those accumulating in the mutants rep- 
resent a biosynthetic intermediate in the class Il-pro- 
cessing pathway (reviewed by Cresswell, 1994a). Class II 
aj3CLlP complexes can be efficiently loaded with antigenic 
peptides in vitro by exposure to low pH in the presence 
of the detergent n-octyl giucoside (GGlc), which induces 
CLIP removal (Riberdy et al., 1992). Only detergents con- 
taining short (8-10 carbon) unbranched carbon chains, 
such as CeGlc, or aliphatic primary amines or carboxylic 
acids of a similar size induce CLIP dissociation (Awe and 
Cresswell, 1994). Introduction of HLA-DM genes into the 
mutant ceil lines results in removal of CLIP and efficient 
peptide loading, suggesting that HLA-DM might be re- 
sponsible for CLIP removal from the aj3CLlP complex and 
subsequent peptide binding in vivo. Thiscould occur either 
directly or by facilitating the trafficking of class II molecules 
to a compartment where appropriate conditions for CLIP 
removal exist. In this study, we show that HLA-DM can 
directly cause CLIP release from aj3CLlP complexes and 
facilitate the in vitro binding of antigenic peptides. 
Results 
Incubation of HLA-DM with apCLlP and Peptide 
Produces SDS-Stable ag Dimers 
The ability of detergents such as CsGlc to induce CLIP 
dissociation led us to determine whether HLA-DM could 
perform this function. For convenience, we used HLA-DM 
precipitated from the class II-negative ceil line TPlDM 
(Denzin et al., 1994) using agarose beads coupled with the 
monocionai antibody (MAb) MaP.DMB-C (a mouse MAb 
specific for the C-terminal region of the HLA-DM6 chain; 
Robbins et at., submitted). For a negative control, MaP.- 
DMB-C immunoprecipitates from the HLA-DM-negative 
ceil line T2 were used. HLA-DR3 aj3CLiP complexes were 
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affinity purified from [~S]methioninslabeled T2.DR3 cells 
as previously described (Awa and Cresswell, 1994) after 
extracting the cells in polyoxyethylene 9 lauryl ether 
(&ES), a detergent that does not facilitate CLIP dissocia- 
tion. The purified radiolabeled af3CLlP was incubated in 
Cl& at pH 4.5 for 2 hr at 37OC, wlth either HLA-DM or a 
control immunoprecipitate and either a HLA-DfWrestritied 
peptide from Chlamydia major outer membrane protein 
(MOMP) or a control peptide from hen egg-white lysozyme 
(HEL). Following neutralization, the samples were ana- 
lyzed by SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE). Figure 1A shows that incubation of a5CLlP and 
MOMP with HLA-DM at low pH (lane 10) resulted in the 
formation of SDS-stable dimers, indicating peptide load- 
ing. Incubation of asCLIP, peptide, and a control immuno- 
precipitate gave only a low level of SDS-stable dimers (Fig- 
ure 1 A, lane 9). SDS-stable dimers were only formed in 
the presence of the HLA-DW-restricted peptide (Figure 
lA, compare lanes 9 and 10 with lanes 11 and 12). HLA- 
DM is located in the lysosomal-like MIIC and therefore 
should be more active at an acidic pH. As expected, incu- 
bation of the aSCLIP with HLA-DM and peptide without 
acidification (Figure 1 A, lanes 7 and 8) resulted in minimal 
formation of SDS-stable dimers. Incubation of af3CLlP 
complexes with peptide and CeGlc at acidic pH (Figure 
1 A, lanes 3 and 4) resulted in SDS-stable dimers indepen- 
dent of the presence of HLA-DM. Similar results were ob- 
tained with a diff erent DRbrestritied peptide derived from 
mycobacterial heat shock protein Hsp85 (data not shown). 
The useof immunoprecipitated HLA-DM in these assays 
raises the possibility that other HLA-DM-associated pro- 
teins could be influencing the formation of peptide-loaded 
a5 dimers. Although no HLA-D&associated radiolabeled 
proteins had been observed in immunoprecipitation exper- 
iments (Denzin et al., 1994) we purified HtA-DM from 
wild-tyg P&la B-lymphoblastoid cell line (B-LCL) to ad- 
dress this question. No contaminating or associated pro- 
teins were present in the HLA-DM preparation (Figure 1 B, 
inset), and it was highly efficient in generating SDS-stable 
dimers from HLA-DR3 a8CLlP complexes in the presence 
of added MOMP peptide. Stable dimers were evident after 
3 hr at 37OC with as little as 2.5 ng of added HLA-DM. 
These data show that HlA-DM is intrinsically capable of 
generating SDS-stabte HLA-DR a8 dimers, requiring no 
accessory proteins to perform this function. 
IAb molecules expressed in the T2 cell line (T2.IAb) 
are also complexed with the CLIP peptide. Labeled I-Ab 
af3CLlP complexes were purified from [%S]methionine- 
labeled T2.lAb cells in C12Ee using an affinity column pre- 
pared with the MAb CerCLIP.1, which recognizes CLIP- 
bound class II molecules (Denzin et al., 1994). The I-Ab 
CLIP complexes were incubated in the presence and ab- 
sence of HlA-DM and the I-Ab-restricted Ea peptide and 
then subjected to SDS-PAGE. The results (Figure 1C) 
demonstrate that human HLA-DM can cause CLIP dissoci- 
ation and peptide loading of the mouse I-Ab ab dimers 
(lanes 5 and 8). Loading is dependent upon the presence 
of HLA-DM and requires an acidic pH (Figure 1 C, compare 
lanes 3 and 4 with lanes 5 and 8). In contrast with HLA 
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Figure 1. HlA-DM Facilitates the Formation of Class II a6-Peptide 
Complexes at Low pli 
Purified [YSjmethionine-labeled aftCLiP complexes were incubated 
with specific or control peptides at 37OC for 2 hr in the presence or 
absence of HLA-DM at pH 4.5 or pH 6.0, as indicated by the presence 
or absence of acetic acid. Samples were neutralized with 1 M Tris, 
when necessary, and analyzed by SDS-PAGE(lO.S%). Peptides were 
included at a final concentration of 166 CM. Where indicated, 1% 
CsGlc was also added. (A) HLA-DR3 af3CLlP plus HlA-DR3-restricted 
MOMP peptide. (9) HLA-DW af3CLlP plus MOMP peptide with purified 
HLA-DM (inset shows SDS-PAGE of purfffed HLA-DM stained with 
Fast Stain). (C) Mouse I-Ab af3CLlP plus I-Ab-restricted Ea peptide. The 
locations of class II a and 6 chains, associated CLIP. and SDS-stable 
ab dimers are indicated on each gel. Mouse I-Ab floppy a6 dimers are 
marked with an arrowhead. M, MOMP peptide; H, HEL peptide; Ea, 
Ea peptide; HoAc. acetic acid; IP, immunoprecipitate. 
class II molecules, incubation of I-Ab af3CLlP molecules 
with 1% CaGlc at acidic pH in the presence of peptide 
does not result in SDS-stable dimers (Figure lC, lane 1). 
An explanation for this observation may be that mouse 
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I-Ab has a higher affinity for human CLIP than HLA-DR3 
(Sette et al., 1995). Collectively, these experiments showed 
that incubation of aDCLIP, peptide, and HLA-DM at low 
pH results in the formation of SDS-stable dimers for both 
human and mouse class II alleles. 
Fractionation of aSCLIP Complexes into 
CerCLIP.l-Reactive and Nonreactive Populations 
Most human B-LCLs have relatively high levels of aDCLIP 
complexeson their cell surface, as determined by staining 
with CerCLIP.l (P. C., unpublished data). CLIP bound to 
HLA-DR3 a/3 dimers in T2.DR3 comprises a nested set of 
I chain peptides (Riberdy et al., 1992). The high level of 
aflCLlP complexes on B-LCL could potentially be ac- 
counted for by the inability of HLA-DM to remove Cer- 
CLIP.1 -reactive peptides. To address this, we purified Cer- 
CLIP.1 -reactive and nonreactive aPCL!P complexes. 
T2.DFi3 cells were labeled with [%]methionine, and the 
radiolabeled lysate was sequentially passed over a Cer- 
CLIP.1 (anti-CLIP) column and then an L243 column (anti- 
HLA-DR ap dimers) to bind to any aPCLlP not bound by 
the CerCLIP.l column. Separation by reversed-phase high 
pressure liquid chromatography (RP-HPLC) demonstrated 
that the CerCLIP.l -reactive and CerCLIP. 1 -nonreactive 
aPCLlP preparations contained two different sets of CLIP 
peptides (Figure 2A). 
We sequenced three peptides,from RP-HPLC fractions, 
two CerCLIP.l reactive (eluting at 82 and 88 min) and one 
CERCLIP.l nonreactive (eluting at 80 min), determining 
the positions containing [3JS]methionine. The sequence 
of CLIP (residues 81-104) is LPKPPKPVSKMRMATPLL- 
MQALPM. With no truncations at the N-terminus, the first 
two signals should be generated on the eleventh and thir- 
teenth cycles. This pattern was observed for the peaks 
eluted from the CerCLIP.l-reactive material. The Cer- 
CLIP.l-nonreactive peak generated signals’on the ninth 
and eleventh cycles, indicating that this peptide lacked 
the first two amino acids (data not shown). 
The two populations of aDCLIP complexes were incu- 
bated at pH 4.5 with either a HLA-DR3-restricted peptide 
(MOMP) or a control peptide (HEL) in the presence and 
absence of HLA-DM. Both CerCLIP.l-positive (Figure 28, 
lanes 3 and 4) and CerCLIP.l-negative (lanes 9 and 10) 
aPCLlP complexes gave increased levels of SDS-stable 
dimers (lanes 4 and 10). These results suggest that HLA- 
DM can use a diverse population of CLIP-bound class II 
molecules as a substrate. The aPCLlP complexes ex- 
pressed on the surface of wild-type cells may represent 
a subset that has not passed through the MIIC and there- 
fore has never come in contact with HLA-DM. Alterna- 
tively, and perhaps more likely, the level of class II mole- 
cules synthesized may be in excess of the amount with 
which the endogenous HLA-DM molecules can effectively 
deal. 
HLA-DM Is Most Active at Acidic pH 
To determine the optimal pH for HLA-DM activity, we incu- 
bated [Yilmethionine-labeled HLA-DR3 aSCLIP com- 
plexes at 37% for 2 hr with MOMP peptide and HLA-DM 
B 
Figure 2. HLA-DM Can Use a Diverse Population of CLIP-Sound 
Class II Molecules as a Substrate 
(A) RP-HPLC analysis of CerCLIP.l-positive (solid line) and Cer- 
CLIP.l-negative CLIP (broken line). Peptides were extracted from 
[“Slmethionine-labeled CerCLIP-reactive or nonreactive aDCLIP com- 
plexes purified from T2.DR3 and separated by RP-HPLC. DPM, disin- 
tegrations per minute. 
(6) SDS-PAGE analysis. CerCLIP.l-positive and CerCLIP.1~negative 
c$CLlP complexes and HIA-DRS-restricted MOMP or control HEL 
peptides were incubated at 37OC for 2 hr in the presence or absence 
of HlA-DM at pH 4.5 or pH 8.0, as indicated by the presence or absence 
of acetic acid (HoAc). Samples were neutralized when necessary and 
analyzed by SDS-PAGE (10.5%). Peptides were included at a final 
concentration of 100 PM. The positions of the individual class II a and 
I3 chains, CLIP, and the afl dimers are indicated on the right. H, HEL 
peptide; M, MOMP peptide. 
immunoprecipitates at a range of pH values from 4.5 to 
8.0. Following neutralization, the samples were separated 
by SDS-PAGE. Quantitation of the percentage of SDS- 
stable dimers formed at each pH by image analysis 
showed that HLA-DM was most active between pH 5 and 
pH 8 (Figure 3A), a range characteristic of MllCs (Peters 
et al., 1991). Control reactions at pH 8.0 and pH 4.5 in 
the absence of HLA-DM showed almost no SDS-stable 
dimer at pH 8.0 and only a small amount at pH 4.5. For 
comparison, we also performed the pH titration in the ab- 
sence of HLA-DM but in the presence of 1% CsGlc. In 
contrast with the wide functional pH range observed for 
HLA-DM, SDS-stable dimers were only efficiently gener- 
ated at pH 4.5 in CsGlc (Figure 3B). 
Kinetics of SDS-Stable ap Dimer Induction 
by HLA-DM In Vitro 
In wild-type B-LCL, HLA-DM expression is much lower 
than that of classical class II molecules, suggesting that 
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Figure 3. ThepH Dependenceof HLA-DR3 SDS-Stable Dimer Forma- 
tion Induced by HLA-DM and CsGlc 
Radiolabeled HLA-DR3 a3CLlP complexes and MOMP peptide were 
added to HlA-DM (A) or C&lc (B), and the pH was adjusted to the 
indicated values by the addition of acetic acid. Following incubation 
at 37OC for 2 hr, samples were neutralized, when necessary, analyzed 
by SDS-PAGE (10.5%), and quantitated by image analysis. Control 
reactions were performed in the absence of HlA-DM or CeGlc at the 
indicated pH. 
HLA-DM must function catalytically. To determine the rate 
at which HLA-DM could convert aSCLIP complexes to 
SDS-stable dimers, radiolabeled GerCLIP.l -purified HLA- 
DR3 aDCLIP and MOMP peptide were added to HLA-DM 
or control immunoprecipitates and incubated at pH 4.5 for 
periods up to 10 hr at 37OC. SDS-PAGE analysis of the 
kinetics of SDS-stable dimer formation is quantitated in 
Figure 4. In the presence of HLA-DM, SDS-stable dimers 
can be detected after only 5 min of incubation at 37OC and 
formation proceeds rapidly for the first 2 hr of incubation, 
finally leveling off at 8 hr. During the 10 hr incubation pe- 
riod, 70% of the aSCLIP was converted to an SDS-stable 
dimer with a tH approximately equal to 1.25 hr. Some SDS- 
stable dimers do form without HlA-DM, which is probably 
a result of spontaneous CLIP dissociation from the aSCLIP 
complex, followed by peptide binding. However, dimer for- 
mation is substantially slower with a ta,+ of greater than 10 
hr (Figure 4). Overall, the data agree well with a catalytic 
function for the HLA-DM protein in converting af3CLlP and 
peptide into SDS-stable dimers, assuming that af3CLlP is 
in excess of HLA-DM (see Discussion). 
75 
--+- HLA-DM 
- Control 
0 1 2 3 4 5 6 7 8 9 10 
Time (hr) 
Figure 4. Kinetics of HLA-DR3 SDS-Stable Dimer Formation by 
HfA-DM 
HLA-DR3 a3CLlP complexes and the HLA-DRSrestricted MOMP pep 
tide were incubated at 37OC for the indicated times in the presence 
and absence of HLA-DM at pH 4.5. Following neutralization, samples 
were analyzed by SDS-PAGE (10.5%). and the percent SDS-stable 
dimer formed at each timepoint was quantitated by image analysis. 
HLA-DM Removes CLIP from HLA-DR3 
aSCLIP Complexes 
The fact that HLA-DM can substitute for CsGlc in the in 
vitro peptide loading assay (see Figure 1) suggests that 
HLA-DM may function by inducing the dissociation of the 
CLIP peptide, allowing subsequent peptide binding. To 
determine whether HLA-DM causes CLIP release, we in- 
cubated radiolabeled HLA-DR3 a5CLlP (CerCLIP.l puri- 
fied) with either HLA-DM or control immunoprecipitates in 
the presence of no peptide or MOMP at pH 4.5 for 8 hr 
at 37OC. Following neutralization, the af3CLlP complexes 
and a5 dimers were separated from free CLIP using conca- 
navalin (Con) A-Sepharose beads. Analysis of the super- 
natants by immunoprecipitation with CerCLIP.l beads fol- 
lowed by SDS-PAGE and fluorography showed that 
HLA-DM induced the dissociation of CLIP from HLA-DR3 
af3CLlP complexes in the presence or absence of MOMP 
(data not shown). CLIP liberated by HLA-DM in the ab- 
sence of MOMP was also examined by RP-HPLC after 
elution from the CerCLIP.l beads by the addition of 10% 
acetic acid. At least four different CLIP peptides were ini- 
tially complexed to the afl dimers (Figure 5A). RP-HPLC 
analysis of CLIP removed by HLA-DM showed an identical 
profile. In the absence of HLA-DM, only a small amount 
of dissociated CLIP was observed by RP-HPLC analysis. 
These data, together with those presented in Figure 2, 
suggest that all CLIP peptides associated with HLA-DR3 
are dissociated by HLA-DM. 
If the only function of HlA-DM is to facilitate CLIP disso- 
ciation, then the rate-limiting step for SDS-stable dimer 
formation should be CLIP removal. Figure 4 shows that 
the generation of SDS-stable dimers in the in vitro assay 
system was rapid; this experiment, however, did not deter- 
mine whether CLIP removal was the rate-limiting step. 
Radiolabeled HLA-DR3 af3CLlP complexes at pH 4.5 were 
therefore incubated at 37OC for various periods of time 
with or without HLA-DM. Following neutralization, the free 
CLIP peptide was immunoprecipitated as described above 
Function of HLA-DM 
159 
Etution Time (min) 
50 75 100 
Elution Time (min) 
50 75 100 0 1 2 3 4 5 6 
Elution Time (min) Time (hr) 
and analyzed by SDS-PAGE. The kineticsof CLIP release 
were also determined in the presence of 1% CsGlc and 
1% CsGlc plus HLA-DM. Results of these experiments are 
shown in Figures 5B and 5C. CLIP release was detected 
after 30 min of incubation and steadily increased through- 
out the incubation period. The rate of CLIP release in the 
absence of peptide (th, - 1 hr) was similar to that of SDS- 
stable drmer formatron (t,,+, - 1.25 hr; see Figure 4). This 
indicates, first, that there is no substantial lag between 
CLIP release and peptide binding and, second, that CLIP 
removal and peptide loading may be coupled (see below). 
HLA-DM did not further accelerate CLIP dissociation in- 
duced by CsGlc (Figure EC), which was much more rapid 
and complete than that induced by HLA-DM alone. 
CerCLIP.1 Blocks the HLA-DM-Induced Formation 
of SDS-Stable afi Dimers 
Since HLA-DM can induce CLIP dissociation, it seems 
reasonable to propose that HLA-DM directly interacts with 
a6CLlP complexes. The CerCLIP.l antibody, recognizing 
the N-terminus of CLIP, might block the interaction and 
prevent CLIP release. CerCLIP.l-purified HLA-DR3 up- 
CLIP complexes were therefore preincubated with Cer- 
CLIP.1 for 30 min at 37OC to allow binding. The antibody- 
af3CLlP mixture was then added to MOMP peptide and a 
HLA-DM immunoprecipitate, and the pH was lowered to 
6.0, a pH at which HLA-DM is active (see Figure 3) and 
antibody can bind, for 3 hr at 37OC. The reactions were 
terminated by neutralization and analyzed by SDS-PAGE. 
The results (Figure 6A, lanes l-3) show that preincubation 
of a5CLlP with no antibody or with a nonspecific MAb 
followed by incubation with HLA-DM and peptide at pH 6.0 
Figure 5. HLA-DM Causes CLIP Dissociation 
from a6CLlP 
(A) RP-HPLC analysis of CLIP released by 
HlA-DM from aftCLIP complexes. HLA-DR a6- 
CLIP complexes purified from a T2.DR3 cell 
lysate with a CerCLIP.1 column were added to 
HlA-DM or control immunoprecipitates in the 
absence of MOMP peptide. Following acidifica- 
tion and incubation at 37OC for 6 hr, the sam- 
ples were neutralized and the HLA-DR a5 di- 
mer was removed with Con A-Bepharose. Free 
CLIP was immunoprecipitated from the super- 
natant with CerCLIP.l beads, 10% acetic acid 
was added, and the dissociated CLIP was sep 
arated by RP-HPLC. Total CLIP bound to the 
starting material and released by 10% acetic 
acid was used as a positive control and is la- 
beled Total. 
(B) SDS-PAGE analysis of the kinetics of HLA- 
DM and &Glc-induced CLIP dissociation from 
HLA-DR3 a6 dimers. CerCLIP.l-purified a6- 
CLIP was incubated with HLA-DM. without 
HLA-DM (control), with CaGIc, and with HLA- 
DM plus CeGlc at pH 4.5 for the indicated times, 
and the CLIP released was immunoprecipi- 
tated and analyzed by SDS-PAGE (10.5%). 
Time of incubation is indicated across the bot- 
tom of the figure and each incubation condition 
is indicated along the left side. 
(C) Quantitation of SDS-PAGE from (B). PD, 
pixel density. 
resulted in 45% and 39.6% SDS-stable dimer formation, 
respectively (Figure 6B). Preincubation with CerCLIP.l re- 
duced stable dimer formation to 15.4%. To ensure that 
the blocking we observed with CerCLIP.l reflected inhibi- 
tion of HLA-DM function, we determined its effect on pep- 
tide loading mediated by CaGlc and also with a6CLlP that 
had been depleted of CerCLIP.l -reactive complexes. 
These results (Figure 6A, lanes 4-9; Figure 6B) showed 
that CerCLIP. 1 is not able to block the CsGlc-induced for- 
mation of SDS-stable dimers, which, although significant, 
is low at pH 6.0 (see Figures 3A and 38) or the HLA-DM- 
induced formation of SDS-stable dimers from CerCLIP.l- 
nonreactive af3CLIP. 
HLA-DM Modulates Peptlde Loading In Vitro 
Although HlA-DM can remove CLIP from uPCLIP com- 
plexes (see Figure 5), creating peptide-receptive a6 di- 
mers, it could potentially facilitate peptide loading by a 
more direct mechanism. To test this hypothesis, we ti- 
trated the amount of peptide required to generate SDS- 
stable dimers from HLA-DR3 af3CLlP complexes facili- 
tated by either CsGlc or HLA-DM. Radiolabeled af3CLlP 
complexes were incubated with HLA-DM or control immu- 
noprecipitates, in the presence or absence of 1% CsGlc, 
with decreasing concentrations of MOMP (5000 nM to 1.6 
nM) or no peptide. Following acidification and incubation 
for 3 hr at 37°C the samples were neutralized, analyzed 
by SDS-PAGE, and quantitated by image analysis. Half- 
maximal peptide loading by HLA-DM was achieved at 5 nM 
peptide (Figure 7) which is a 160-fold lower concentration 
than that required for CeGlc (600 nM peptide). Since CLIP 
release from the aSCLIP complex by CsGlc is more effi- 
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Figure 6. MAbCerCLIP.l Blocks the Formation of SDS-Stable Dimers 
by HtA-DM 
(A) SDS-PAGE (10.5%) analysis and (B) quantitation. CerCLIP.l- 
positive and CerCLIP.1~negative HLA-DR3 a6CLlP complexes were 
preincubated with CerCLIP.1, a control MAb, GAP.A3, or no MAb for 
30 min at 37OC and then added to MOMP peptide and HLA-DM immu- 
noprecipitates or to control immunoprecipitates and the detergent, 
CsGlc (1% final concentration). The pH was lowered to 6.0 for 3 hr at 
37OC, and the samples were neutralized and analyzed by SDS-PAGE. 
cient than CLIP release by HLA-DM (see Figures 58 and 
5C) but peptide loading is more efficient in the presence 
of HLA-DM than 1% CsGlc, it seems likely that HLA-DM 
is directly involved in the peptide loading of the class II 
a8 dimer. The alternative hypothesis, that CeGlc has an 
inhibitory effect on peptide binding while it effectivelyfacili- 
tates CLIP release, is negated by the observation that load- 
ing in CsGlc with HLA-DM is more efficient than in CsGlc 
alone (Figure 7). 
Alternative Forms of Class II Molecules 
as HLA-DM Substrates 
Intermediates in I chain proteolysis other than CLIP have 
been observed in association with class II molecules. 
These fragments contain both the transmembrane region 
and cytoplasmic domain (Pieters et al., 1991; Marie et al., 
1994; Amigorena et al., 1995). One such intermediate, 
leupeptin-induced protein (LIP), accumulates in the pres- 
ence of the protease inhibitor leupeptin and is a 21 kDa 
N-terminal fragment of the I chain. To determine whether 
uPCLIP is an obligatory substrate for HLA-DM, we purified 
HLA-DR3 a81 and aSLIP complexes from [35S]methionine- 
labeled wild-type Pala cells by labeling in the presence of 
- Control 
- DM 
- CgGlc 
- DM + C3Glc 
1 10 100 1000 10000 
Concentration MOMP Peptide (MA) 
Figure 7. HLA-DM Facilitates Peptide Loading 
HtA-DR3 af3CLlP complexes were incubated with control or HtA-DM 
immunoprecipitates, 1% CsGlc, or 1% CsGlc and a HLA-DM immuno- 
precipitate, with decreasing concentrations (6000 nM to 1.6 nM) of 
HLA-DR3-restricted MOMP peptide. The pH was lowered to 4.5 by 
the addition of acetic acid, and the reactions were incubated at 37OC 
for 3 hr. Following neutralization, samples were analyzed by SDS- 
PAGE (10.5%) and the percent SDS-stable dimers was quantitated 
by image analysis. 
monensin (Machamer and Cresswell, 1984) or leupeptin 
(Blum and Cresswell, 1988), respectively. Radiolabeled 
aBLIP, a8l, or a8CLlP complexes were added to HLA-DM 
or control immunoprecipitates and MOMP at pH 4.5. After 
incubation at 37X for3 hr and neutralization, the samples 
were analyzed by SDS-PAGE. Surprisingly, HLA-DM in- 
duced the generation of SDS-stable a8 dimers from a8LlP 
(Figures 8A and 8B), causing about a P-fold increase. This 
effect was reproducible in three separate experiments. 
For a8l, no difference was observed, indicating that a81 
cannot serve as a substrate for HLA-DM (Figures 8A and 
88). HLA-DR3 a8CLlP was a better substrate for HLA-DM 
than abLIP, since a 3-fold increase in the level of SDS- 
stable dimers was observed, compared with only a 2-fold 
increase for a8LlP (Figure 8B). LIP is clearly visible on the 
gel in Figure 8A after incubation with HLA-DM, suggesting 
that proteolysis during the incubation is not occurring and 
that a8LlP may be a genuine substrate. However, it is 
possible that a8 dimers associated with smaller I chain 
fragments (Marie et al., 1994) may be present and that 
these are the true substrates. 
To determine whether HLA-DM can also remove endog- 
enous peptides from mature class II a8 dimers, HLA-DR3 
a3 dimers were affinity purified using an L243 column from 
metabolically labeled wild-type Pala cells. The HLA-DR3 
a8 dimers were added to HLA-DM or control immunopre- 
cipitates in the presence or absence of MOMP. The reac- 
tion mixtures were acidified, incubated at 37OC for 3 hr, 
neutralized, analyzed by SDS-PAGE, and quantitated by 
image analysis. The results argue that HLA-DM is unable 
to remove peptides from mature class II molecules, be- 
cause incubation in the absence of peptide did not reduce 
the amount of SDS-stable dimers (Figure BC, compare 
lanes 3 and 4; Figure 8D). Incubation of the a8 dimers 
with HLA-DM and MOMP did result in a small increase in 
SDS-stabledimers(from57.4% to85.5%; Figure8D). This 
is probably due to a small population of a8CLlP complexes 
in the af3 dimers purified from the wild-type cells. 
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Discussion 
A number of hypothetical mechanisms for the action of 
HLA-DM have been suggested (Cresswell, 1994b; Fling 
et al., 1994; Morriset al., 1994). These include thepossibil- 
ities that HLA-DM may function as a chaperone, escorting 
immature a9 dimers to the appropriate environment where 
peptides are available; that HLA-DM may bind peptides 
in a lysosomal compartment and deliver them to available 
class If molecules in a different compartment; that HLA- 
DM may function as a’sinK for CLIP, thus driving an equi- 
librium from a3CLlP to empty a3 dimers, which would then 
be receptive to peptides; or that HLA-DM might actively 
induce CLIP dissociation. The data presented here agree 
with the last hypothesis. Thus, HLA-DM under mildly acidic 
in vitro conditions induces CLIP dissociation from aSCLIP 
and, in the presence of a suitable antigenic peptide, SDS- 
stable af3-peptide complexes are efficiently generated. 
None of the other three suggestions is totally invalidated 
by the data presented here, although no evidence was 
found for CLIP association with HLA-DM after incubation 
with af3CLlP (data not shown), which would argue against 
the CLIP sink hypothesis. A variant of that hypothesis that 
suggests that HLA-DM might have peptidase activity and 
thus drive an equilibrium from aDCLIP to empty a9 dimers 
by degrading CLIP is also not supported by the data. Fig- 
ure 5A shows that the RP-HPLC profile of CLIP released 
by HLA-DM is identical to the profile of CLIP initially associ- 
ated with the aSCLIP complex. Thus, the data clearly indi- 
cate that HLA-DM in some way actively induces CLIP dis- 
sociation from afXLlP complexes. 
To be completely satisfactory, any scheme proposed 
to explain the mechanism of action of HLA-DM should 
incorporate the finding that CeGlc, similar detergents, or 
primary aliphatic amines and carboxylic acids can also 
Figure 6. HLA-DM Can Facilitate Loading of 
a3CLlP and aBLIP Complexes, but not a61 or 
Mature +Peptide Complexes 
(A) HlA-DRI a61 and a6LlP complexes, puri- 
fied from ~S]methionine-labeled wild-type 
Pala cells labeled in the presence of monensin 
or leupeptin, and a6CLlP complexes were 
added to HLA-DM or control immunoprecipi- 
tates. MOMP peptide was added, the pH was 
lowered to 4.5, and the samples were incu- 
bated at 37OC for 3 hr. The samples were neu- 
tralized and analyzed by SDS-PAGE (10.5%). 
The location of I chain, class II a and 6 chains, 
a6 dimers, LIP, and CLIP are indicated to the 
right of the gel. 
(B) Guantitatlon of gels from (A). 
(C) Mature HlA-DR3 a6 dimers were purified 
by afflnity chromatography from [3bS]methic- 
nine-labefed Pala cells and added to HLA-DM 
or control immunoprecipltates in the presence 
or absence of MOMP peptide. Following acidifi- 
cation and incubation at 37OC for 3 hr, samples 
were neutralized and analyzed by SDS-PAGE 
(10.5%). The location of class II a and 6 chains, 
a6 dimers, and CLIP are indicated to the right 
of the gel. 
(D) Ouantitation of gels from (C). 
facilitate CLIP dissociation and the generation of peptide- 
loaded SDS-stable dimers (Awa and Cresswell, 1994). A 
model that potentially fulfills this criterion is presented in 
Figure 9. The model argues that af3 dimers associated 
with CLIP can occur in two conformations, one of which, 
a9*, has a low affinity for CLIP and is the target for both 
the detergent effect and HlA-DM. At neutral pH, the equi- 
librium strongly favors the high affinity form. At lower pH, 
the equilibrium shifts toward the low affinity form. CaGlc 
or similar detergents preferentially act upon af3*CLIP, fa- 
cilitating CLIPdissociation. ThisgeneratesfreeaS*, which 
binds available peptkfes and generates a stable af3-pep- 
tide complex. The detergent effect is not seen in the case 
of I-Ab CLIP complexes (Figure lC), which suggests that 
susceptibility to detergent-induced CLIP dissociation is 
not a universal feature of class II molecules. We have 
previously suggested a relationship between the ability of 
primary aliphatic chains to disrupt aSCLIP association and 
the SDS instability of af3CLlP (Awa and Cresswell, 1994). 
Interestingly, I-Ab molecules from T2.l-Ab show the pres- 
ence of substantial amounts of “fk)ppy” SDS-stable dimers 
(Sadegh-Nasseri and Germain, 1991) indicated by the 
arrowhead in Figure lC, which are weak or absent from 
HLA-DR3 molecules isolated from T2.DR3 (see Figures 
Pmide 
Figure 9. Model for HLA-DM Function 
See Discussion. 
1A and 1 B). The correlation between lack of susceptibility 
to CaGlc-induced CLIP dissociation and the presence of 
floppy SDS-stable dimers is in agreement with this hypoth- 
esis if one assumes that the floppy I-Ab dimers are af.XLlP 
complexes rather than empty afi dimers. Conceivably, 
however, the floppy dimers may be empty, perhaps be- 
cause of some CLIP dissociation under the alkaline elution 
conditions used in affinity purification. The amount of 
floppy dimers is unchanged in the presence of peptide 
and HLA-DM (Figure lC), indicating that they may not be 
a good substrate and perhaps suggesting that the pres- 
ence of class II-bound CLIP is required for HLA-DM func- 
tion. These questions remain to be investigated. 
HLA-DM, in the proposed model, transiently binds aj3*- 
CLIP causing CLIP release, facilitates peptide association 
with the empty ajj* dimers, and then repeats the process 
with additional aP*CLIP complexes, thus catalyzing pep- 
tide loading. While no physical evidence for a class II- 
HLA-DM interaction is currently available, the ability of 
CerCLIP.l to block HLA-DM-mediated peptide loading of 
aj3CLlP complexes (Figures 6A and 6B) suggests that a 
transient physical interaction must occur. The size of an 
antibody molecule precludes a precise determination of 
the class II-HLA-DM interaction site based on the ability 
of CerCLIP.l to block HLA-DM-induced CLIP dissociation. 
However, consistent with previous suggestions that CLIP 
associates with polymorphic regions of class II molecules 
(Sette et al., 1995; Awa and Cresswell, 1994; Malcherek 
et al., 1995) it has recently been shown that it binds like 
a conventional peptide with the CerCLIP.l-reactive N-ter- 
minus at one end of the binding groove, corresponding to 
the C-terminal end of the 51 a helix and the N-terminal 
end of the al a helix (Ghosh et al., submitted). HLA-DR3 
afi dimers containing a mutant a chain with an additional 
N-linked glycan at position 94 in the a2domain accumulate 
as a9CLlP complexes, even in HLA-DM-positive cells 
(Mellins et al., 1994). This site is almost directly below the 
end of the binding groove occupied by the N-terminus of 
CLIP (J. Park and D. Wiley, personal communication). The 
inhibitory effect of the novel glycan and that of CerCLIP.l 
could therefore be explained if HtA-DM interacts laterally 
with that face of the class II molecules. This hypothesis 
clearly requires further testing. 
Incorporated into the model (Figure 9) is the idea that 
peptide association with the a$ dimer following CLIP dis- 
sociation occurs prior to HLA-DM dissociation. We have 
no evidence in favor of this, except the observation that 
peptide loading in the presence of CsGlc is more efficient 
when HLA-DM is added (Figure 7). If HLA-DM simply facili- 
tated the generation of empty af3*, as shown for CaGlc, 
then one would not expect this enhanced efficiency. One 
explanation is that empty class II molecules transiently 
associated with HLA-DM have a higher affinity for peptides 
other than CLIP than do free empty afi dimers. Alterna- 
tively, HLA-DM could play a more direct role as a peptide 
donor. In experiments in which we have isolated HLA-DM 
molecules from [35S]methionine-labeled B-LCL, we have 
been unable to demonstrate associated [YS]methionine- 
labeled peptides by acid elution and RP-HPLC analysis 
(L. K. D. and P. C., unpublished data). However, methio- 
nine is a relatively uncommon amino acid in proteins, and 
we cannot say that we have unambiguously shown that 
HLA-DM does not bind peptides. 
The final stage of the generation of ap-peptide com- 
plexes shown in Figure 9 indicates that the a5-peptide 
complex dissociates from HLA-DM, freeing the HLA-DM 
molecule for further interactions with afXLIP. That mature 
a5 peptide complexes are themselves poor substrates for 
HlA-DM is shown in Figure 8, which, based on the hypo- 
thetical scheme shown, we would interpret by arguing that 
any equilibrium involving these complexes would heavily 
favor the aj3 form as opposed to the afl’ form. The data 
clearly fit with observations favoring a role for newly syn- 
thesized class II molecules, as opposed to recycling class 
II molecules, in class II-restricted antigen processing. 
The suggestion that HLA-DM repeatedly interacts with 
aj3CLlP complexes, in an essentially catalytic role, is 
based on a number of findings. First, HLA-DM has a long t/n 
in vivo (Denzin et al., 1994) arguing that it is not consumed 
during peptide loading. Second, HLA-DM is present in low 
amounts relative to HLA-DR in B-LCL. Based on compara- 
tive labeling efficiencies, relative yields following affinity 
purification, and Western blotting experiments, we esti- 
mate that the total HLA-DM expressed in B-LCL is less 
than 5% of the total HLA-DR. The majority of the assays 
performed in this work involved the addition of a5CLlP 
complexes isolated from approximately 0.5 x 1 OsT2.DR3 
cells, which express wild-type levels of HLA-DR3 on the 
Cell surface, to HLA-DM immunoprecipitated from 1 O8 T2/ 
DM cells. Thus, the af3CLlP complexes are clearly in ex- 
cess. In addition, 2.5 ng of purified HLA-DM, equivalent 
to 0.6 x lo6 wild-type cells based on purification yields, 
gave 19% SDS-stable dimers using af3CLlP from 0.5 x 
1 06T2.DR3 cells in 3 hr at 37OC (Figure 1 B). This increased 
e-fold after 18 hr of incubation at 37X (data not shown), 
suggesting that HLA-DM is functioning substoichiometri- 
tally and therefore catalytically. 
Perhaps the most surprising finding is the observation 
that HLA-DR af3LlP complexes may serve as a HLA-DM 
substrate (Figures 8A and 88). No CLIP is visible in the 
aDLIP preparations (Figure 8A), arguing that contaminat- 
ing aj3CLlP cannot be the source of the HLA-DM-induced 
SDS-stable dimers. Low M, I chain fragments, running on 
the dye front in Figure 8A, might ba associated with a 
subset of the af3 dimers, and these complexes could be 
the true substrates. However, the data suggest that aj3LlP 
is probably a HLA-DM substrate and clearly show that af3l 
is not a substrate. It is possible that intact I chain blocks 
the interaction of ap with HlA-DM, whereas LIP does not, 
and the C-terminal region of the I chain missing from LIP 
may be responsible for this. Combined with the CerCLIP.l 
blocking data (Figure 6) this might suggest that the 
C-terminal region of the I chain associates with the region 
of the al and 51 domains of the af3 dimer closest to where 
the N-terminus of CLIP is located. A potential complicating 
factor, however, is that apI complexes are stable nona- 
mers (Roche et al., 1991) whereas aDLIP complexes in 
solution can dissociate into a5LlP trimers (Newcomb and 
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Cresswell, 1993b). Clearly, the accessibility of a3 dimers 
involved in a nonameric structure may be quite different 
from that in a simple trimeric structure. 
It has been shown that asLIP complexes accumulate 
in dense compartments with sedimentation properties in 
Percoll gradients similar to MllCs (Marie et al., 1994; Rob- 
bins et al., submitted), which one could simply interpret 
as an accumulation of af3LlP in the MIIC. However, it re- 
mains a possibility that af3LlP complexes accumulate in a 
different, earlier compartment than the HLA-Dhl-containing 
MIICs, as suggested by Blum and colleagues (Marie et 
al., 1994) but that the two compartments have similar 
densities. Further cleavage of the I chain may be required 
for a9 dimers to move into MllCs and become accessible 
to HtA-DM, an idea consistent with the possibility that 
signals for MIIC localization may be in the ap dimers them- 
selves. This may be the putative signal for endosomal 
localization in the lumenal region of the class II molecule 
suggested by the work of Chervonsky et al. (1994). 
Experimental Procedures 
Cell Lines 
The T x B hybrid cell line ,174 x CEMTP (class II-; T2) (Salter et 
al., 1966) its derivatives transfected with the HlA-DM genes (T2/DM) 
(Denzin et al., 1994) and the HLA-DR3 genes (T2.DR3) (Riberdy and 
Cresswell, 1992) and the EBV-transformed Pala B-LCL (DR3.Dwl7) 
(Riberdy et al., 1994) have been described elsewhere. T2 transfected 
with I-Ab genomic DNAs (T2.FA3 was a gift from Dr. Ned Braunstein, 
Columbia University. The cell lines were maintained in Iscove’s DMEM 
(GIBCO BRL) with 5% calf serum (GIBCO BRL) in the presence of 
5% CO2 at 37OC. The T2/DM cell line was grown in the presence of 
500 @ml puromycin (Sigma). 
Peptldes 
All peptides were synthesized by the Keck Foundation Biotechnology 
Resource Laboratory (Yale University). Peptides were purified by RP- 
HPLC and laser desorption mass spectrometry indicated that all were 
a single species. The HlA-DRI-restricted peptides MOMP (QASLALS- 
YRLNMFTP; Riberdy et al., 1992) and Hsp65 (KTIATDEEARR; Geluk 
et al., 1992) are derived from residues 251-266 of the major outer 
membrane protein of Chlamydia trachomatis and 3-l 3 of the mycobac- 
terial heat shock protein Hsp65, respectively. The I-A*-binding HEL 
peptide (NTDGSTDYGILQINSRY; Babbitt et al., 1965) is derived from 
residues 46-61 of hen egg lysoxyme. The Err peptide (FEAQGAfANI- 
AVD; Rudensky et ?I., 1991) is derived from residues 56-71 of the 
I-Ea chain and is I-Aa restricted. 
Antlbodirs 
The hybridoma cell lines t.243 (anti-HLA-DR aj3; Lampson and Levy, 
1960), DA6.147 (anti-fitA-DR a chain; Guy et al., 1962) CerCLIP.1 
(anti-CLIP24; Denzin et al., 1994) MaP.DMBC (Robbinset al., submit- 
ted), and GAP.AS (anti-HLA-A3; Berger et al., 1962) have been de- 
scribed elsewhere. For affinity chromatography and immunoprecipita- 
tions with beads, L243, CerCLIP.1, MaP.DMB-C, and normal mouse 
IgG were coupled to CNBr-activated Biogel AlSm (Bio-Rad) at a con- 
centration of 1 mg of antibody per milliliter of gel. 
Affinity Purification of Radiolabeled Class II ap Dimers 
The affinity purification of [“S]methionine-labeled HLA-DR3 a6 dimers 
and af3CLlP complexes from Pala B-LCL and T2.DR3 using the MAb 
L243 was performed as previously described (Awa and Cresswell, 
1994). Purification of I-Ab af3CLlP complexes was similarly performed 
from [?S]methionine-labeled T2.l.Ab cells using CerCLIP.1 affinity 
chromatography. For purification of HLA-DR3 a6CLlP complexes that 
were CerCLIP.l reactive and nonreactive, a radiolabeled T2.DR3 ly 
sate was passed twice over a CerCLIP.1 column and then over a L243 
column to bind any remaining HLA-DR3 af3CLIP. All columns were 
eluted with 0.1 M Tris (pH 11.5). 0.1% CIIEO. The eluted fractions were 
neutralized with 1 M acetic acid and stored at 4OC until use. 
HLA-DA3 apI complexes were purified using a DA6.147 column 
from a cell extract of Pafa cells labeled with PSjmethionine for 4 hr 
in the presence of IO pM monensin (Sigma) as described previously 
(Machamer and Cresswell. 1964). For purification of aj3LlP complexes, 
an L243 column was used and Pala cells were similarly labeled and 
then chased for 15 hr in the presence of 0.5 mM leupeptin (Sigma) 
(Blum and Cresswell, 1966). 
HLA-DM lmmunopreclpltatlons 
T2/DM or control T2 cells were extracted for 30 min on ice in TS buffer 
(pH 7.4) containing 1% Triton X-100 (Sigma), 0.5 mM PMSF, 0.1 mM 
TLCK at 1 x IO to 2 x IO” cells per milliliter. The lysates were 
pracleared overnight at 4OC with normal rabbit serum and pro- 
tein A-Sepharose (Sigma) and then incubated with 25-50 pl of 
MaP.DMB-C beads for 1 hr at 4OC. The beads were washed three 
times with 0.1% C12E8, TS (pH 7.4) and stored at -20°C until use. 
Each immunoprecipitate is equivalent to 1 x lo8 cells. 
Purlflcatlon of HLA-DM 
Pala B-LCLs (14 x IO@) were extracted for 30 min on ice in 2% C12E8 
in TS (pH 7.4) containing 0.5 mM PMSF and 5 mM iodoacetamide. 
Glycoproteins were purified by affinity chromatography using Con 
A-Sepharose 48 (Sigma) and eluting in 0.1% C12Eo in TS (pH 7.4) 
containing 5% a-methyl mannoside (Sigma). The purified glycopro- 
teins (42 mg) were applied to a MaP.DMB-C affinity column and HLA- 
DM was eluted in 0.6% CHAPS (Sigma), 0.1 M NaCI, 0.05 M acetate 
(pH 3.0). Neutralized fractions were analyzed for HLA-DM by Western 
blotting using a rabbit anti-peptide antibody (R.DMB-C) specific for 
the HLA-DM6 cytoplasmic domain (Denzin et al., 1994). Approximately 
40 ug of HLA-DM was recovered, which was uncontaminated with 
additional proteins based on SDS-PAGE and staining with Fast Stain 
(Zoion Research Inwrporated). Quantitation was based on amino acid 
analysis of the purified material. 
SDS Stability Assay 
HLA-DM or control (T2) immunoprecipitates or purified HLA-DM was 
incubated with 20.000-40,000 cpm of radiolabeled aSCLIP, aSLIP, 
aj3I, or af3-peptide complexes in TS buffer (pH 8.0) 0.1% C12E0. Spe- 
cific peptide, control peptide, or no peptide was added, and the pH 
was adjusted as indicated by the addition of 1 M acetic acid. Where 
indicated, 1% CsGlc was also included in the reaction mixture. Pep- 
tides were used at a concentration of 100 uM in all experiments except 
for the MOMP titrations (Figure 7). Following incubation at 37OC for 
2-3 hr, samples were neutralized with 1 M Tris, mixed with IO x nonre- 
ducing Laemmli sample buffer and separated by SDS-PAGE (10.5%) 
without boiling. Gels were fixed for 20 min and treated with Enlight- 
ening (Dupont New England Nuclear) for 20 min prior to drying and film 
exposure. Bands were quantitated with a Bit-Rad 65250 Molecular 
Imager, subtracting a background obtained by integrating a blank area 
of the appropriate size on each gel. 
Antibody blocking experimentswere performed as described above, 
except that the affinity-purified CerCLIP.l-negative and CerCLIP.l- 
positive &CLIP complexes were incubated with 2 ug of affinity-purified 
CerCLIP.1, GAP.AS. or no antibody at 37OC for 30 min before incuba- 
tion with HLA-DM and antigenic peptide at pH 6.0. 
Analysis of CLIP Disaoclatlon 
CerCLIP.1 affinity-purified HLA-DR3 af3CLIP complexes were added 
to HtA-DM or control immunoprecipitations in the presence or absence 
of MOMP at pH 4.5. At various times, the samples were neutralized 
with 1 M Tris and diluted to 1 ml with TS (pH 7.4) 0.1% C12E8. Con 
A-Sepharose beads (100 pl; Sigma) were added, and the tubes were 
incubated overnight at 4OC to remove the HLA-DR and HLA-DR CLIP 
complexes. The Con A-Sepharose beads were pelleted, and the su- 
pernatantswere immunoprecipitated with CerCLIP.1 beads (50 ul) and 
analyzed by SDS-PAGE or RP-HPLC. 
RP-HPLC 
CLIP peptides were eluted from CerCLIP.1 beads by the addition of 
Cdl 
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10% acetic acid and analyzed by RP-HPLC as previously described 
(Awa and Cresswell, 1994). CLIP peptides eluted from a5CLlP corn- 
pfexes by the addition of 10% acetic acid were similarly analyzed. 
Profiles of labeled peptides were generated from 0.5 ml fractions wl- 
lected and analyzed on a liquid scintillation counter. 
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